PFKFB3 is overexpressed in numerous cancers including PDAC [27, 28]; this finding led to the development of the specific small-molecule inhibitor 3PO and then more potent 3PO derivatives: PFK15 and PFK158 [24]. This evidence concerns the gene PFKFB3 and cancer.